 |
市場調查報告書
商品編碼
1461288
跟骨骨骺炎治療市場，依疾病類型、依藥物、依應用、依給藥途徑、依配銷通路、依地理位置Severs Disease Treatment Market, By Disease Type, By Drug, By Application, By Route of Administration, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計 2024 年全球跟骨骨骺炎治療市場價值為 13.4 億美元，預計到 2031 年將達到 18.7 億美元，2024 年至 2031 年年複合成長率(CAGR) 為 4.9%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2023年 | 2023/2024 年市場規模： | 13.4 億美元 |
| 歷史數據： | 2019年至2023年 | 預測期： | 2024年至2031年 |
| 預測期間 2023/2024 至 2030/2031 年複合成長率： | 4.90% | 2030/2031 價值預測： | 18.7 億美元 |
各種疾病治療市佔率 (%)，依地區，2024 年
塞弗氏症，也稱為跟骨骨骺炎，是活躍兒童足跟疼痛的常見原因。這是由於孩子進行跑步和跳躍等高衝擊力活動時，跟骨（跟骨）的生長板受到壓力和損傷而引起的。由於生長板尚未完全形成，這會反覆拉動生長板，從而導致發炎和疼痛。它通常影響 8 至 14 歲的兒童，因為他們的腳跟骨正在快速生長。跟骨過度生長暫時超過了生長板韌帶的強度，從而引起症狀。治療的目的是在生長板完全形成時減少活動並緩解症狀。
市場動態：
全球塞弗氏症治療市場的推動因素是兒童參與體育活動的增加以及家長對足部和腳踝疾病的認知不斷提高。此外，不斷發展的醫療基礎設施和越來越多的醫療診斷和治療選擇也推動了市場的成長。但塞弗氏症常被誤診為跟腱炎或足底筋膜炎，一定程度上抑制了市場。此外，物理治療等替代疼痛管理療法也構成了課題。關鍵機會包括制定先進的治療方案、利用遠距醫療以及針對滲透率不足的地區。
研究的主要特點：
- 該報告深入分析了全球塞弗氏症治療市場，並提供了預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%），以2023年為基準年。
- 它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
- 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
- 它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）介紹了全球塞弗氏症治療市場的主要參與者。
- 本研究涵蓋的主要公司包括阿斯特捷利康、Horizon Therapeutics plc、賽諾菲、諾華公司、Sun Pharmaceutical Industries Ltd.、Cipla Inc.、LEO Pharma A/S、AbbVie Inc.、Mylan NV、Teva Pharmaceutical Industries Ltd.。
- 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球塞弗疾病治療市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
- 利害關係人可以透過用於分析全球塞弗氏症治療市場的各種策略矩陣輕鬆做出決策。
目錄
第1章：研究目標與假設
- 研究目標
- 假設
- 縮寫
第 2 章：市場概覽
- 報告說明
- 市場定義和範圍
- 執行摘要
- 市場機會圖
第 3 章：關鍵見解
- 市場動態
- 促進要素
- 限制
- 機會
- 影響分析
- 害蟲分析
- 波特分析
- 技術進步
- 合併、收購和合作場景
- 最近的產品核准
- 公司市佔率分析
- 確定每個地區的關鍵參與者
- 監管場景
- 定價分析
第 4 章：2019 年至 2031 年全球跟骨骨骺炎治療市場（依疾病類型）
- 介紹
- 急性
- 慢性的
第 5 章：全球跟骨骨骺炎治療市場（依藥物），2019 - 2031
- 介紹
- 雙氯芬酸
- 依托度酸
- 消炎痛
- 塞來昔布
- 其他（萘普生等）
第 6 章：2019 年至 2031 年全球跟骨骨骺炎治療市場（依類型）
- 介紹
- 在櫃檯
- 處方
第 7 章：2019 年至 2031 年全球跟骨骨骺炎治療市場（依給藥途徑）
- 介紹
- 口服
- 注射用
- 其他（專題等）
第 8 章：全球跟骨骨骺炎治療市場（依配銷通路），2019 年 - 2031 年
- 介紹
- 醫院藥房
- 零售藥局
- 網路藥局
第 9 章：2019 年至 2031 年全球跟骨骨骺炎治療市場（依地區）
- 介紹
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- 東協
- 亞太其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 中東其他地區
- 中東
- 海灣合作理事會
- 以色列
- 中東其他地區
- 非洲
- 南非
- 北非
- 中非
第 10 章：公司簡介 - 全球跟骨骨骺炎治療市場
- AstraZeneca
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽
- Horizon Therapeutics plc
- Sanofi
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- LEO Pharma A/S
- AbbVie Inc.
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lonza
- Lupin
- Dr. Reddy's Laboratories Ltd.
- IBSA Institut Biochimique SA
第 11 章：參考文獻與研究方法
- 參考
- 研究方法論
簡介目錄
Product Code: CMI6737
The global Sever's Disease Treatment Market is estimated to be valued at USD 1.34 Bn in 2024 and is expected to reach USD 1.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2023/2024: | US$ 1.34 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2023/2024 to 2030/2031 CAGR: | 4.90% | 2030/2031 Value Projection: | US$ 1.87 Bn |
Severs Disease Treatment Market Share (%), By Region, 2024
Sever's disease, also known as calcaneal apophysitis, is a common cause of heel pain in active children. It is caused by the growth plate of the heel bone (calcaneus) being stressed and injured as the child engages in high-impact activities like running and jumping. As the growth plate is not yet fully formed, this repetitively pulls on the growth plate which leads to inflammation and pain. It typically affects children between ages 8-14, as their heel bones are growing rapidly. The excessive heel bone growth temporarily outstrips the strength of the growth plate ligaments causing symptoms. Treatment aims to reduce activity and relieve symptoms while the growth plate fully forms.
Market Dynamics:
The global Sever's disease treatment market is driven by the rising participation of children in sports activities and growing awareness among parents regarding foot and ankle conditions. Moreover, the developing healthcare infrastructure and increasing access to medical diagnosis and treatment options is also fueling the market growth. However, frequent misdiagnosis of Sever's disease as Achilles tendinitis or plantar fasciitis restraints the market to some extent. Furthermore, alternative pain management therapies like physiotherapy pose a challenge. Key opportunities include development of advanced treatment protocols, leveraging telemedicine, and targeting underpenetrated regions.
Key Features of the Study:
- This report provides an in-depth analysis of the global Sever's disease treatment market, and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global Sever's disease treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- The key companies covered as a part of this study include AstraZeneca, Horizon Therapeutics plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Cipla Inc., LEO Pharma A/S, AbbVie Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Lupin, Dr. Reddy's Laboratories Ltd., and IBSA Institut Biochimique SA.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global Sever's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sever's disease treatment market.
Detailed Segmentation:
- Disease Type:
- Acute
- Chronic
- Drug:
- Diclofenac
- Etodolac
- Indomethacin
- Celecoxib
- Others
- Type:
- Over-the-counter
- Prescription
- Route of Administration:
- Oral
- Parenteral
- Others (Topical, etc.)
- Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- AstraZeneca
- Horizon Therapeutics plc
- Sanofi
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- LEO Pharma A/S
- AbbVie Inc.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lonza
- Lupin
- Reddy's Laboratories Ltd.
- IBSA Institut Biochimique SA
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Drug
- Market Snapshot, By Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
- Market Opportunity Map
3. Key Insights
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Pest Analysis
- Porters Analysis
- Technological Advancements
- Merger, Acquisition and Collaboration Scenario
- Recent Product Approvals
- Company Market Share Analysis
- Identification of Key Players in each Region
- Regulatory Scenario
- Pricing Analysis
4. Global Sever's Disease Treatment Market, By Disease Type, 2019 - 2031 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
- Acute, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Chronic, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
5. Global Sever's Disease Treatment Market, By Drug, 2019 - 2031 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
- Diclofenac, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Etodolac, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Indomethacin, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Celecoxib, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Others (Naproxen, etc.) , 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
6. Global Sever's Disease Treatment Market, By Type, 2019 - 2031 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
- Over-the-counter, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Prescription, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
7. Global Sever's Disease Treatment Market, By Route of Administration, 2019 - 2031 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
- Oral, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Parenteral, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Others (Topical, etc.), 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
8. Global Sever's Disease Treatment Market, By Distribution Channel, 2019 - 2031 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
- Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
9. Global Sever's Disease Treatment Market, By Region, 2019 - 2031 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2020 - 2031, (US$ Billion)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest Of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Middle East
- Middle East
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
- GCC
- Israel
- Rest of the Middle East
- Africa
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
- South Africa
- North Africa
- Central Africa
10. Company Profiles - Global Sever's Disease Treatment Market
- AstraZeneca
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Horizon Therapeutics plc
- Sanofi
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- LEO Pharma A/S
- AbbVie Inc.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lonza
- Lupin
- Dr. Reddy's Laboratories Ltd.
- IBSA Institut Biochimique SA
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
骨骼發育不良藥物市場 - 按發育不良類型、治療、配銷通路- 全球預測
骨形成蛋白(BMP)的全球市場:實際成果與預測(2019年～2030年)
進行性肌肉骨化症市場：按產品、給藥途徑和最終用戶 - 全球預測 2024-2030
骨形成蛋白(BMP)2全球市場:2024年![骨髓增生性疾病藥物/治療市場規模 - 依疾病類型（Ph+ CML、Ph- MPN [真性紅血球增多症、原發性血小板增多症、骨髓纖維化]）、藥物類別（酪胺酸激酶、JAK）、給藥途徑、最終用途和預測，2024 年 - 2032](/sample/img/cover/42/1481293.png)
骨髓增生性疾病藥物/治療市場規模 - 依疾病類型（Ph+ CML、Ph- MPN [真性紅血球增多症、原發性血小板增多症、骨髓纖維化]）、藥物類別（酪胺酸激酶、JAK）、給藥途徑、最終用途和預測，2024 年 - 2032
全球骨骼發育不良市場：預測（2024-2029）
轉移性骨病市場（治療：藥物、放射治療、手術介入和腫瘤消融治療）- 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測
骨髓增生性疾病市場至2030年的預測：按類型、診斷和篩檢方法、治療方案、最終用戶和地區的全球分析
骨髓增生性疾病治療市場、份額、規模、趨勢、行業分析報告：按類型、按治療、按最終用途、按地區、按細分市場、預測，2023-2032 年
骨形態發生蛋白市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型、按應用、地區和競爭細分
▼